CS192549B2 - Method of preparation of the chinazoline derivatives - Google Patents

Method of preparation of the chinazoline derivatives

Info

Publication number
CS192549B2
CS192549B2 CS755147A CS514775A CS192549B2 CS 192549 B2 CS192549 B2 CS 192549B2 CS 755147 A CS755147 A CS 755147A CS 514775 A CS514775 A CS 514775A CS 192549 B2 CS192549 B2 CS 192549B2
Authority
CS
Czechoslovakia
Prior art keywords
preparation
chinazoline derivatives
chinazoline
derivatives
Prior art date
Application number
CS755147A
Other languages
Czech (cs)
English (en)
Inventor
John Ch Danilewicz
Anthony G Evans
Allan L Ham
Original Assignee
Thomson Colin
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomson Colin, Pfizer filed Critical Thomson Colin
Priority to CS778426A priority Critical patent/CS192535B2/cs
Priority to CS778425A priority patent/CS192534B2/cs
Publication of CS192549B2 publication Critical patent/CS192549B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS755147A 1974-07-25 1975-07-21 Method of preparation of the chinazoline derivatives CS192549B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS778426A CS192535B2 (en) 1974-07-25 1977-12-15 Method of preparing derivatives of quinazoline
CS778425A CS192534B2 (en) 1974-07-25 1977-12-15 Method of preparing derivatives of quinazoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25

Publications (1)

Publication Number Publication Date
CS192549B2 true CS192549B2 (en) 1979-08-31

Family

ID=10344259

Family Applications (1)

Application Number Title Priority Date Filing Date
CS755147A CS192549B2 (en) 1974-07-25 1975-07-21 Method of preparation of the chinazoline derivatives

Country Status (7)

Country Link
AT (1) AT344178B (fr)
BE (1) BE831654A (fr)
CS (1) CS192549B2 (fr)
ES (4) ES439690A1 (fr)
HU (1) HU174961B (fr)
PL (6) PL103791B1 (fr)
SU (5) SU578874A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators

Also Published As

Publication number Publication date
ES439690A1 (es) 1977-07-01
PL193423A1 (pl) 1978-04-24
SU613723A3 (ru) 1978-06-30
PL193422A1 (pl) 1978-06-05
BE831654A (fr) 1976-01-23
PL103797B1 (pl) 1979-07-31
PL193421A1 (pl) 1978-04-24
PL104615B1 (pl) 1979-08-31
HU174961B (hu) 1980-04-28
SU634671A3 (ru) 1978-11-25
PL103789B1 (pl) 1979-07-31
ES455986A1 (es) 1978-06-01
SU858563A3 (ru) 1981-08-23
PL193420A1 (pl) 1978-04-24
AT344178B (de) 1978-07-10
SU625606A3 (ru) 1978-09-25
SU578874A3 (ru) 1977-10-30
ATA525275A (de) 1977-11-15
PL103791B1 (pl) 1979-07-31
PL103798B1 (pl) 1979-07-31
ES455984A1 (es) 1978-06-01
ES455985A1 (es) 1978-06-16
PL193419A1 (pl) 1978-04-24
PL99427B1 (pl) 1978-07-31

Similar Documents

Publication Publication Date Title
BG27744A3 (en) Method of obtaining of hynazolin derivatives
GB1488062A (en) Derivatives of 2-phenyl-benzofurane
GR59205B (en) New preparation method of methoxy-2-benzamides derivative
BG31503A3 (en) Method for obtaining the derivatives of octahjdroindolhinolzine
JPS51125082A (en) Preparation method of 77 substitutedd88aminomethyll isoflavon derivatives
CH613193A5 (en) Process for the preparation of novel 2-arylamino-2-imidazoline derivatives
CH613683A5 (en) Process for the preparation of secoprostaglandins
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
JPS51125089A (en) Preparation method of piperazinopyrimidine derivatives
GB1519646A (en) Derivatives of eburnamenine
CS190461B2 (en) Method of preparation of the substituted s-alcylthiocarbanates
IL48565A0 (en) Method of preparation of 3-methylenecephams
JPS51125088A (en) Preparation method of new benzhydryloxyyalkylamine derivatives
ZA752255B (en) Preparation of 5-nitromidazole derivatives
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
ZA75976B (en) Process for the preparation of cis-vincamine
EG11656A (en) Process for the preparation of propanolamin derivatives
CS192549B2 (en) Method of preparation of the chinazoline derivatives
KE2992A (en) Process for the preparation of 7-amino-delta3-cephem derivatives
IL47083A0 (en) Method for the preparation of chromene derivatives
CS191271B2 (en) Method of preparation of the 2-deutero-3-fluor-d-alanine
CH613457A5 (en) Process for the preparation of 7-methoxycephalosporin derivatives
GR64923B7 (en) Method for the preparation of benzylidenic derivatives
ZA757455B (en) Method of preparation of 3-methylenecephams
ZA752149B (en) Derivatives of hexahydrodibenzofuran-3-one